Arlene M Heberden, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-7000 |
Ms. Heather Tayne Garreau, RN Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Vamc Black Hills, Fort Meade, SD 57741 Phone: 605-720-7170 Fax: 605-720-7171 |
Travis Engle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 |
Dena Marie Hunt, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 |
Rebecca Marie Wojahn, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-2511 |
Amanda Hopson, CNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-347-7000 |
Dianna Lee Monahan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 113 Comanche Rd, Fort Meade, SD 57741 Phone: 605-720-7132 |
News Archive
Exploring complex reasons behind hesitancy for new vaccinations and better education for healthcare professionals is key to boosting global uptake of immunization against diseases and viruses including Covid-19, a study shows.
The main goals of the Melanoma Group at the Spanish National Cancer Research Centre are to identify biomarkers of tumour progression and to validate novel therapeutic targets in melanoma.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.
A new study from the Regenerative Bioscience Center at the University of Georgia is the first to suggest that COVID-19 does not directly damage taste bud cells.
Scientists at the Universities of Birmingham and Amsterdam hope to have found a new neurobiological marker to help recognize patients with post-traumatic stress disorder (PTSD).
› Verified 8 days ago